USAID Announces $20M In Support For CEPI For Emerging Diseases Vaccine Development

CEPI: USA joins CEPI to support the development of epidemic vaccines
“The U.S. Agency for International Development, USAID, [on Friday] announced US$20 million in financial support of CEPI to advance the development of vaccines against emerging infectious diseases. … The funding — which will be provided by USAID over a five-year period from 2020 and subject to Congressional approval on an annual basis — will be used to support CEPI’s vital vaccine development programs against its current priority diseases: Lassa fever, Middle Eastern Respiratory Syndrome (MERS), Nipah, Chikungunya, Rift Valley Fever, and Ebola…” (10/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.